Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
Holding CERO?
Track your performance easily
CERO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $12.80
Previous Close$0.22
Volume8.68M
Average Volume (3M)64.08M
Market Cap
$32.78M
Enterprise Value$34.59M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.80M
Price to Earnings (P/E)―
Beta-2.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding150,312,572
10 Day Avg. Volume353,858,175
30 Day Avg. Volume64,082,985
Standard Deviation0.21
R-Squared0.01
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)-1.08
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.95
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CERo Therapeutics Holdings News
PremiumMarket News
3 Penny Stocks to Watch Now, 11/19/24
PremiumMarket News
3 Penny Stocks to Watch Now, 11/14/24
PremiumCompany Announcements
CERo Therapeutics Welcomes Shami Patel to Board After ResignationOwnership Overview
47.40% Insiders
0.03% Mutual Funds
2.02% Other Institutional Investors
50.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CERO FAQ
What was CERo Therapeutics Holdings’s price range in the past 12 months?
CERo Therapeutics Holdings lowest stock price was $0.06 and its highest was $12.80 in the past 12 months.
What is CERo Therapeutics Holdings’s market cap?
Currently, no data Available
When is CERo Therapeutics Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CERo Therapeutics Holdings’s earnings last quarter?
Currently, no data Available
Is CERo Therapeutics Holdings overvalued?
According to Wall Street analysts CERo Therapeutics Holdings’s price is currently Overvalued.
Does CERo Therapeutics Holdings pay dividends?
CERo Therapeutics Holdings does not currently pay dividends.
What is CERo Therapeutics Holdings’s EPS estimate?
CERo Therapeutics Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CERo Therapeutics Holdings have?
CERo Therapeutics Holdings has 150,312,580 shares outstanding.
What happened to CERo Therapeutics Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CERo Therapeutics Holdings?
Among the largest hedge funds holding CERo Therapeutics Holdings’s share is Saba Capital Management. It holds CERo Therapeutics Holdings’s shares valued at N/A.
---
CERo Therapeutics Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $378.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 11.2%
Last 30 Days ▲ 78.7%
Last 30 Days ▲ 78.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.12%
Trailing 12-Months
Company Description
CERo Therapeutics Holdings
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
---